Chromocell Therapeutics Stock Forward View - Relative Strength Index
| CHRODelisted Stock | USD 16.50 1.25 8.20% |
Chromocell Stock outlook is based on your current time horizon.
As of today, The value of RSI of Chromocell Therapeutics' share price is at 53 suggesting that the stock is in nutural position, most likellhy at or near its resistance level. The main idea of RSI analysis is to track how fast people are buying or selling Chromocell Therapeutics, making its price go up or down. Momentum 53
Impartial
Oversold | Overbought |
Using Chromocell Therapeutics hype-based prediction, you can estimate the value of Chromocell Therapeutics from the perspective of Chromocell Therapeutics response to recently generated media hype and the effects of current headlines on its competitors.
Chromocell Therapeutics after-hype prediction price | USD 16.5 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as delisted stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Chromocell |
Chromocell Therapeutics Additional Predictive Modules
Most predictive techniques to examine Chromocell price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Chromocell using various technical indicators. When you analyze Chromocell charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Previous Relative Strength Index | Relative Strength Index | Trend |
| 53.48 | 53.48 |
| Check Chromocell Therapeutics Volatility | Backtest Chromocell Therapeutics | Information Ratio |
Chromocell Therapeutics Trading Date Momentum
| On February 26 2026 Chromocell Therapeutics was traded for 16.50 at the closing time. The top price for the day was 17.53 and the lowest listed price was 13.76 . There was no trading activity during the period 0.0. Lack of trading volume on February 26, 2026 did not affect price variability. The overall trading delta against the current closing price is 7.58% . |
Chromocell Therapeutics Related Equities
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Chromocell Therapeutics stock to make a market-neutral strategy. Peer analysis of Chromocell Therapeutics could also be used in its relative valuation, which is a method of valuing Chromocell Therapeutics by comparing valuation metrics with similar companies.
| Risk & Return | Correlation |
Chromocell Therapeutics Market Strength Events
Market strength indicators help investors to evaluate how Chromocell Therapeutics stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Chromocell Therapeutics shares will generate the highest return on investment. By undertsting and applying Chromocell Therapeutics stock market strength indicators, traders can identify Chromocell Therapeutics entry and exit signals to maximize returns.
Chromocell Therapeutics Risk Indicators
The analysis of Chromocell Therapeutics' basic risk indicators is one of the essential steps in accurately forecasting its future price. The process involves identifying the amount of risk involved in Chromocell Therapeutics' investment and either accepting that risk or mitigating it. Along with some essential techniques for forecasting chromocell stock prices, we also provide a set of basic risk indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
| Mean Deviation | 5.31 | |||
| Semi Deviation | 5.79 | |||
| Standard Deviation | 8.68 | |||
| Variance | 75.33 | |||
| Downside Variance | 37.71 | |||
| Semi Variance | 33.54 | |||
| Expected Short fall | (7.41) |
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.
Story Coverage note for Chromocell Therapeutics
The number of cover stories for Chromocell Therapeutics depends on current market conditions and Chromocell Therapeutics' risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Chromocell Therapeutics is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Chromocell Therapeutics' long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.
Contributor Headline
Latest Perspective From Macroaxis
Chromocell Therapeutics Short Properties
Chromocell Therapeutics' future price predictability will typically decrease when Chromocell Therapeutics' long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of Chromocell Therapeutics often depends not only on the future outlook of the potential Chromocell Therapeutics' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Chromocell Therapeutics' indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 5.6 M | |
| Cash And Short Term Investments | 513.4 K |
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in real. You can also try the Idea Analyzer module to analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas.
Other Consideration for investing in Chromocell Stock
If you are still planning to invest in Chromocell Therapeutics check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Chromocell Therapeutics' history and understand the potential risks before investing.
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk |